Cash Flow from Operating Activities: A company's cash flows from operations.
ADC Therapeutics SA (ADCT) had Cash Flow from Operating Activities of $-80.42M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$18.84M |
|
$-56.65M |
|
$0.84M |
|
$18.00M |
|
$62.99M |
|
$-44.15M |
|
$-11.24M |
|
$-55.39M |
|
$-55.39M |
|
$-56.65M |
|
$-56.65M |
|
$-56.65M |
|
$-56.65M |
|
$-44.15M |
|
$-43.31M |
|
113.74M |
|
113.74M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$318.75M |
|
$0.00M |
|
$2.81M |
|
$321.56M |
|
$64.60M |
|
$114.47M |
|
$456.14M |
|
$520.75M |
|
$-199.18M |
|
$-199.18M |
|
$-199.18M |
|
112.50M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-80.42M |
$-0.26M |
|
$94.05M |
|
$250.87M |
|
$264.56M |
|
$13.69M |
|
$4.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.93 |
|
-- |
|
-- |
|
-1.35 |
|
-0.57 |
|
95.56% |
|
-234.34% |
|
-234.34% |
|
-- |
|
-294.03% |
|
-300.68% |
|
$-80.69M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.05 |
|
0.72 |
|
125.09 |
|
28.44% |
|
28.44% |
|
-17.62% |
|
66.87% |
|
$-1.77 |
|
$-0.71 |
|
$-0.71 |
|